High-dose rituximab and anti-MAG-associated polyneuropathy

Neurology
Susanne RenaudA Steck

Abstract

Rituximab has been administered successfully in patients with polyneuropathy associated with antibodies to myelin-associated glycoprotein (anti-MAG). The authors present a follow-up study with high-dose rituximab. Increase of rituximab from 375 mg/m2 to a dose of 750 mg/m2 was well tolerated and led to clinical improvement in four of eight patients, along with improvement of nerve conduction velocities and a reduction of anti-MAG antibody titers.

Citations

Feb 3, 2009·Der Nervenarzt·A SchröderR Gold
Mar 26, 2011·Journal of Neurology·Emilien DelmontC Desnuelle
Sep 16, 2010·Current Treatment Options in Neurology·Marinos C Dalakas
Apr 6, 2007·Nature Clinical Practice. Neurology·Gerd Meyer zu HörsteBernd C Kieseier
Sep 25, 2008·Nature Clinical Practice. Neurology·Joachim M BaehringFred H Hochberg
Mar 11, 2010·Journal of Clinical Neuromuscular Disease·Stephan A Botez, David N Herrmann
Mar 10, 2011·Journal of Clinical Neuromuscular Disease·Homam IbrahimAziz Shaibani
Jan 26, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S MatàF Lolli
Mar 20, 2012·The Journal of Clinical Investigation·Michael A MaurerJan D Lünemann
Apr 26, 2011·Journal of Neuroinflammation·Gehan A Mostafa, Laila Y Al-Ayadhi
Jul 14, 2009·Molecular Medicine·Andreas A Argyriou
Sep 14, 2006·Current Opinion in Neurology·Bernd C KieseierHans-Peter Hartung
Sep 14, 2006·Current Opinion in Neurology·Andreas J SteckSusanne Renaud
Sep 22, 2007·Current Opinion in Neurology·Pierre Lozeron, David Adams
Jul 29, 2009·Leukemia & Lymphoma·Sasa A ZivkovićSuzanne Lentzsch
Aug 16, 2013·Immunopharmacology and Immunotoxicology·Nizar SouayahPeter Siao Tick-Chong
Oct 3, 2006·Expert Review of Neurotherapeutics·Sasa A Zivković
Jul 16, 2009·Expert Opinion on Pharmacotherapy·Laurent Magy, Jean-Michel Vallat
Nov 26, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jean-Marc LégerCristina Muntean
Apr 27, 2013·La Presse médicale·Ricard Rojas-GarcíaIsabel Illa
Apr 13, 2011·Neurología : publicación oficial de la Sociedad Española de Neurología·J J Poza Aldea
Jan 10, 2012·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Gehan Ahmed Mostafa, Laila Yousef Al-Ayadhi
Jun 18, 2011·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Gabriella ZaraM Ermani
Jan 11, 2016·Journal of the Peripheral Nervous System : JPNS·Ruxandra Iancu FerfogliaJean-Marc Léger
Sep 1, 2009·Autoimmunity Reviews·Thomas DörnerUNKNOWN International Roundtable on B cells as Therapeutic Target for Intervention
May 27, 2009·Neuromuscular Disorders : NMD·Karl StieglbauerFranz T Aichner
Nov 13, 2008·International Immunopharmacology·Hakan M GürcanA Razzaque Ahmed
Sep 4, 2008·Clinical Lymphoma & Myeloma·Arun Vijay, Morie A Gertz
Sep 1, 2015·La Revue de médecine interne·Q ReynaudP Cathébras
Feb 28, 2007·Neurologic Clinics·Justin Y Kwan
Nov 18, 2015·Journal of Neuropathology and Experimental Neurology·Rina HashimotoGen Sobue
May 27, 2009·British Journal of Haematology·Vickie McDonald, Maria Leandro
Jan 24, 2007·Journal of Neurochemistry·Richard H Quarles
May 28, 2008·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Jürgen RechHendrik Schulze-Koops
Jun 15, 2007·Journal of the Peripheral Nervous System : JPNS·Luana BenedettiAngelo Schenone
Jun 23, 2011·Journal of the Peripheral Nervous System : JPNS·Hans-Peter HartungRichard A C Hughes
Jan 5, 2011·Journal of the Peripheral Nervous System : JPNS·Eduardo Nobile-Orazio
Oct 19, 2011·Journal of the Peripheral Nervous System : JPNS·Berengere GrusonBruno Royer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.